Top compounds associated with response to RBM20


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC -0.12 0.01
mRNA PD318088 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA manumycin A CTRPv2 pan-cancer AAC 0.082 0.01
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.089 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.085 0.02
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA CIL70 CTRPv2 pan-cancer AAC 0.13 0.02
Download CSV